Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: Q4Q400
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 116 | 120 | PF00656 | 0.590 |
CLV_C14_Caspase3-7 | 175 | 179 | PF00656 | 0.562 |
CLV_NRD_NRD_1 | 101 | 103 | PF00675 | 0.559 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.499 |
CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.357 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.565 |
CLV_PCSK_KEX2_1 | 111 | 113 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.647 |
CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.504 |
CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.542 |
CLV_PCSK_SKI1_1 | 225 | 229 | PF00082 | 0.641 |
CLV_PCSK_SKI1_1 | 285 | 289 | PF00082 | 0.580 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.480 |
DOC_CDC14_PxL_1 | 270 | 278 | PF14671 | 0.592 |
DOC_CYCLIN_RxL_1 | 222 | 231 | PF00134 | 0.505 |
DOC_PP1_RVXF_1 | 169 | 175 | PF00149 | 0.573 |
DOC_PP2B_LxvP_1 | 28 | 31 | PF13499 | 0.445 |
DOC_USP7_MATH_1 | 176 | 180 | PF00917 | 0.568 |
DOC_USP7_MATH_1 | 198 | 202 | PF00917 | 0.712 |
DOC_USP7_MATH_1 | 223 | 227 | PF00917 | 0.479 |
DOC_USP7_MATH_1 | 263 | 267 | PF00917 | 0.548 |
DOC_WW_Pin1_4 | 29 | 34 | PF00397 | 0.558 |
LIG_14-3-3_CanoR_1 | 169 | 175 | PF00244 | 0.620 |
LIG_14-3-3_CanoR_1 | 260 | 270 | PF00244 | 0.640 |
LIG_14-3-3_CanoR_1 | 294 | 302 | PF00244 | 0.538 |
LIG_14-3-3_CanoR_1 | 38 | 47 | PF00244 | 0.498 |
LIG_14-3-3_CanoR_1 | 93 | 100 | PF00244 | 0.538 |
LIG_14-3-3_CterR_2 | 308 | 311 | PF00244 | 0.608 |
LIG_Actin_WH2_2 | 13 | 29 | PF00022 | 0.484 |
LIG_BRCT_BRCA1_1 | 255 | 259 | PF00533 | 0.488 |
LIG_CaM_IQ_9 | 292 | 307 | PF13499 | 0.463 |
LIG_eIF4E_1 | 47 | 53 | PF01652 | 0.386 |
LIG_FHA_1 | 156 | 162 | PF00498 | 0.574 |
LIG_FHA_2 | 77 | 83 | PF00498 | 0.585 |
LIG_LIR_Gen_1 | 154 | 164 | PF02991 | 0.604 |
LIG_LIR_Gen_1 | 173 | 182 | PF02991 | 0.540 |
LIG_LIR_LC3C_4 | 136 | 139 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 120 | 126 | PF02991 | 0.534 |
LIG_LIR_Nem_3 | 154 | 160 | PF02991 | 0.542 |
LIG_LIR_Nem_3 | 16 | 21 | PF02991 | 0.413 |
LIG_LIR_Nem_3 | 173 | 177 | PF02991 | 0.538 |
LIG_LIR_Nem_3 | 256 | 262 | PF02991 | 0.572 |
LIG_LIR_Nem_3 | 297 | 302 | PF02991 | 0.543 |
LIG_LIR_Nem_3 | 45 | 50 | PF02991 | 0.588 |
LIG_LIR_Nem_3 | 79 | 84 | PF02991 | 0.619 |
LIG_PTB_Apo_2 | 125 | 132 | PF02174 | 0.372 |
LIG_SH2_CRK | 18 | 22 | PF00017 | 0.424 |
LIG_SH2_STAP1 | 153 | 157 | PF00017 | 0.526 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.491 |
LIG_SH2_STAT5 | 205 | 208 | PF00017 | 0.625 |
LIG_SH2_STAT5 | 77 | 80 | PF00017 | 0.433 |
LIG_SH3_3 | 6 | 12 | PF00018 | 0.443 |
LIG_Sin3_3 | 247 | 254 | PF02671 | 0.481 |
LIG_SUMO_SIM_par_1 | 249 | 257 | PF11976 | 0.567 |
LIG_SxIP_EBH_1 | 199 | 208 | PF03271 | 0.523 |
LIG_UBA3_1 | 250 | 258 | PF00899 | 0.582 |
LIG_WRC_WIRS_1 | 259 | 264 | PF05994 | 0.536 |
MOD_CK1_1 | 261 | 267 | PF00069 | 0.678 |
MOD_CK2_1 | 153 | 159 | PF00069 | 0.584 |
MOD_CK2_1 | 76 | 82 | PF00069 | 0.581 |
MOD_GlcNHglycan | 13 | 16 | PF01048 | 0.480 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.680 |
MOD_GlcNHglycan | 263 | 266 | PF01048 | 0.669 |
MOD_GlcNHglycan | 289 | 293 | PF01048 | 0.418 |
MOD_GlcNHglycan | 296 | 299 | PF01048 | 0.343 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.608 |
MOD_GSK3_1 | 151 | 158 | PF00069 | 0.586 |
MOD_GSK3_1 | 203 | 210 | PF00069 | 0.660 |
MOD_GSK3_1 | 290 | 297 | PF00069 | 0.546 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.559 |
MOD_LATS_1 | 36 | 42 | PF00433 | 0.478 |
MOD_N-GLC_1 | 127 | 132 | PF02516 | 0.366 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.655 |
MOD_NEK2_1 | 26 | 31 | PF00069 | 0.620 |
MOD_NEK2_1 | 280 | 285 | PF00069 | 0.566 |
MOD_NEK2_1 | 288 | 293 | PF00069 | 0.347 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.604 |
MOD_PKA_2 | 170 | 176 | PF00069 | 0.571 |
MOD_PKA_2 | 198 | 204 | PF00069 | 0.665 |
MOD_PKA_2 | 26 | 32 | PF00069 | 0.576 |
MOD_PKA_2 | 92 | 98 | PF00069 | 0.504 |
MOD_Plk_1 | 127 | 133 | PF00069 | 0.456 |
MOD_Plk_1 | 7 | 13 | PF00069 | 0.436 |
MOD_Plk_2-3 | 76 | 82 | PF00069 | 0.553 |
MOD_ProDKin_1 | 29 | 35 | PF00069 | 0.560 |
MOD_SUMO_rev_2 | 136 | 145 | PF00179 | 0.455 |
TRG_DiLeu_BaEn_1 | 99 | 104 | PF01217 | 0.638 |
TRG_DiLeu_BaEn_2 | 108 | 114 | PF01217 | 0.593 |
TRG_DiLeu_BaEn_4 | 109 | 115 | PF01217 | 0.501 |
TRG_DiLeu_LyEn_5 | 99 | 104 | PF01217 | 0.519 |
TRG_ENDOCYTIC_2 | 164 | 167 | PF00928 | 0.612 |
TRG_ENDOCYTIC_2 | 18 | 21 | PF00928 | 0.424 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.514 |
TRG_ENDOCYTIC_2 | 81 | 84 | PF00928 | 0.560 |
TRG_ER_diArg_1 | 100 | 102 | PF00400 | 0.550 |
TRG_ER_diArg_1 | 111 | 113 | PF00400 | 0.489 |
TRG_ER_diArg_1 | 169 | 172 | PF00400 | 0.627 |
TRG_ER_diArg_1 | 25 | 28 | PF00400 | 0.454 |
TRG_ER_diArg_1 | 302 | 305 | PF00400 | 0.470 |
TRG_ER_diArg_1 | 307 | 310 | PF00400 | 0.544 |
TRG_Pf-PMV_PEXEL_1 | 101 | 106 | PF00026 | 0.580 |
TRG_Pf-PMV_PEXEL_1 | 112 | 116 | PF00026 | 0.592 |
TRG_Pf-PMV_PEXEL_1 | 225 | 230 | PF00026 | 0.600 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0P3M6 | Trypanosomatidae | 26% | 100% |
A0A3R7ME57 | Trypanosoma rangeli | 29% | 100% |
A0A3S7X6V8 | Leishmania donovani | 93% | 100% |
A4HLP9 | Leishmania braziliensis | 71% | 100% |
D0A6C5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9AHN7 | Leishmania infantum | 93% | 100% |
E9B424 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
V5BTW6 | Trypanosoma cruzi | 31% | 100% |